Literature DB >> 20353146

Peripheral neuropathy: differential diagnosis and management.

Hend Azhary1, Muhammad U Farooq, Minal Bhanushali, Arshad Majid, Mounzer Y Kassab.   

Abstract

Peripheral neuropathy has a variety of systemic, metabolic, and toxic causes. The most common treatable causes include diabetes mellitus, hypothyroidism, and nutritional deficiencies. The diagnosis requires careful clinical assessment, judicious laboratory testing, and electrodiagnostic studies or nerve biopsy if the diagnosis remains unclear. A systematic approach begins with localization of the lesion to the peripheral nerves, identification of the underlying etiology, and exclusion of potentially treatable causes. Initial blood tests should include a complete blood count, comprehensive metabolic profile, and measurement of erythrocyte sedimentation rate and fasting blood glucose, vitamin B12, and thyroid-stimulating hormone levels; specialized tests should be ordered if clinically indicated. Lumbar puncture and cerebrospinal fluid analysis may be helpful in the diagnosis of Guillain-Barré syndrome and chronic inflammatory demyelinating neuropathy. Electrodiagnostic studies, including nerve conduction studies and electromyography, can help in the differentiation of axonal versus demyelinating or mixed neuropathy. Treatment should address the underlying disease process, correct any nutritional deficiencies, and provide symptomatic treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20353146

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  28 in total

1.  Use of graded Semmes Weinstein monofilament testing for ascertaining peripheral neuropathy in people with and without diabetes.

Authors:  Muideen T Olaiya; Robert L Hanson; Karen G Kavena; Madhumita Sinha; Dawn Clary; Mark B Horton; Robert G Nelson; William C Knowler
Journal:  Diabetes Res Clin Pract       Date:  2019-03-25       Impact factor: 5.602

2.  Improvement of pyridoxine-induced peripheral neuropathy by Cichorium intybus hydroalcoholic extract through GABAergic system.

Authors:  Farkhonde Hasannejad; Malek Moein Ansar; Mohammad Rostampour; Edris Mahdavi Fikijivar; Behrooz Khakpour Taleghani
Journal:  J Physiol Sci       Date:  2019-02-02       Impact factor: 2.781

Review 3.  Complementary and Alternative Medicine for Painful Peripheral Neuropathy.

Authors:  Vanessa Baute; Danielle Zelnik; Jarret Curtis; Fatemeh Sadeghifar
Journal:  Curr Treat Options Neurol       Date:  2019-09-02       Impact factor: 3.598

4.  Autoantibodies binding to stathmin-4: new marker for polyneuropathy in primary Sjögren's syndrome.

Authors:  Sabrina Duda; Torsten Witte; Martin Stangel; Jan Adams; Reinhold E Schmidt; Niklas T Baerlecken
Journal:  Immunol Res       Date:  2017-12       Impact factor: 2.829

5.  Self-Injurious Behavior Secondary to Cytomegalovirus-Induced Neuropathy in an SIV-Infected Rhesus Macaque (Macaca mulatta).

Authors:  Elizabeth A Clemmons; Sanjeev Gumber; Elizabeth Strobert; Mollie A Bloomsmith; Sherrie M Jean
Journal:  Comp Med       Date:  2015-06       Impact factor: 0.982

6.  Diffuse large B-cell lymphoma relapse presenting as extensive neurolymphomatosis.

Authors:  Pankaj Nepal; Prem P Batchala; Patrice K Rehm; Camilo E Fadul
Journal:  Neuroradiol J       Date:  2020-05-13

Review 7.  Origins of Phantom Limb Pain.

Authors:  Damien P Kuffler
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

8.  Dual pathology as a result of spinal stenosis and vitamin B12 deficiency.

Authors:  Mohammed Shakil Patel; Zurqa Rasul; Philip Sell
Journal:  Eur Spine J       Date:  2011-05-08       Impact factor: 3.134

9.  Therapeutic implications of protein homeostasis in demyelinating peripheral neuropathies.

Authors:  Samuel M Lee; Lih-Shen Chin; Lian Li
Journal:  Expert Rev Neurother       Date:  2012-09       Impact factor: 4.618

10.  Trigeminal electrophysiology: a 2 x 2 matrix model for differential diagnosis between temporomandibular disorders and orofacial pain.

Authors:  Gianni Frisardi; Giacomo Chessa; Gianfranco Sau; Flavio Frisardi
Journal:  BMC Musculoskelet Disord       Date:  2010-07-01       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.